SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1173)9/17/1998 9:06:00 AM
From: BMcV  Read Replies (1) | Respond to of 10280
 
Agreed that it is not their chemistry (though with 50+ PhDs they're not slouches either) but their patents that make SEPR's story so compelling. One thing to add is that judging by the fact that they are signing big pharmas to major licensing deals on very good terms, SEPR's patent position must be quite strong as well.



To: Biomaven who wrote (1173)9/17/1998 3:44:00 PM
From: Thomas M.  Respond to of 10280
 
I'm going to stop posting to this thread, since you say everything better than me. <g>

Tom



To: Biomaven who wrote (1173)9/17/1998 11:59:00 PM
From: chirodoc  Read Replies (1) | Respond to of 10280
 
<<<< a start-up drug discovery program, and its interesting Versicor subsidiary.

i guess i had only heard about chiral
know very little about start-up and nothing about versicor
where do i go for more info?
is it on this thread?
any other place?
thanks

curtis


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News